WATERTOWN, Mass., May 7, 2018 /PRNewswire/ — Affera, Inc, a private medical device company focused on innovative cardiac arrhythmia treatment solutions, announced today its integrated platform will be highlighted in eight scientific sessions at the Heart Rhythm Society 2018 (HRS) meeting in Boston, Massachusetts. Affera’s revolutionary lesion […]
Tag: arrhythmias
Abbott Expands Cardiac Arrhythmias Portfolio with FDA Clearance of Advanced Mapping Catheter
ABBOTT PARK, Ill., May 3, 2018 /PRNewswire/ — Abbott (NYSE: ABT) today announced U.S. Food and Drug Administration (FDA) clearance of the Advisor™ HD Grid Mapping Catheter, Sensor Enabled™. Advisor HD Grid employs a new design that allows physicians to see things differently, […]